Empresa Intercept Pharmaceuticals, Inc.
Acciones
ICPT
US45845P1084
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 341
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23/02/17 |
Andrew Saik
DFI | Director of Finance/CFO | 54 | 21/06/21 |
M. Berrey
CTO | Chief Tech/Sci/R&D Officer | 57 | 09/06/21 |
Jose Truzman
SEC | Corporate Secretary | - | - |
Rocco Venezia
AUD | Comptroller/Controller/Auditor | 48 | 01/01/16 |
General Counsel | 55 | 11/01/21 | |
Corporate Officer/Principal | 60 | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23/02/17 |
Director/Board Member | 55 | 08/11 | |
Stefano Pasi
BRD | Director/Board Member | - | 08/11 |
Michele Cera
BRD | Director/Board Member | - | 08/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 41 825 966 | 40 940 614 ( 97,88 %) | 0 | 97,88 % |
Información de la empresa
Intercept Pharmaceuticals, Inc.
305 Madison Avenue
07960, Morristown
+646 747 1000
http://www.interceptpharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+10,09 % | 114 mil M | |
+12,72 % | 107 mil M | |
-5,57 % | 22,22 mil M | |
-0,67 % | 21,28 mil M | |
-4,64 % | 18,8 mil M | |
-6,32 % | 17,51 mil M | |
-39,36 % | 17,17 mil M | |
+6,46 % | 14,14 mil M | |
+34,80 % | 12,2 mil M |